• BAPTA-AM: Mapping Calcium From Mitochondria to Axons

  2026-08-13

  A translational framework for using BAPTA-AM to test whether intracellular Ca2+ is a driver, mediator, or consequence of mitochondrial dysfunction, axonal degeneration, apoptosis, and related calcium-dependent phenotypes.

• DAPI (hydrochloride) for Immune-Cell Assays

  2026-08-12

  DAPI (hydrochloride) can do more than label nuclei: it can anchor cell-count, DNA-content, and assay-quality decisions in tumor immunology. This article connects its staining chemistry with the enzalutamide–myeloid-cell findings reported in Cancer Immunology Research while clearly separating measurement from mechanistic inference.

• Toremifene Citrate: Breast Cancer Research Workflows

  2026-08-12

  Build more informative estrogen receptor experiments with Toremifene Citrate, from receptor-binding assays and MCF-7 proliferation studies to carefully controlled oral dosing models. This guide combines practical workflow parameters, tamoxifen-comparison logic, and troubleshooting for reproducible breast cancer and endocrinology research.

• Targeted mRNA Nanoparticles Protect the Poststroke BBB

  2026-08-11

  Gao et al. developed mannose receptor-targeting lipid nanoparticles that deliver IL-10 mRNA to ischemic brain regions and reinforce protective microglial polarization. In mouse stroke models, this strategy reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and alleviated neurological deficits, with activity reported when treatment began as late as 72 hours after stroke.

• Annexin V-Cy5 for Translational Apoptosis

  2026-08-10

  A mechanistic and strategic guide to using Annexin V-Cy5 apoptosis detection in zebrafish microglia and other translational models, with emphasis on separating cell death from lysosomal digestion failure, designing orthogonal validation, and interpreting fluorescence data responsibly.

• Translational Antibody Detection for Variant Vaccines

  2026-08-09

  How secondary-antibody strategy can connect variant-vaccine biology with reproducible, orthogonal immune-readout workflows.

• OCT2/MATE1 Inhibition by 5-HT3 Antiemetics

  2026-08-08

  George and colleagues systematically compared five 5-HT3 receptor antagonist drugs for inhibition of renal OCT2- and MATE1-mediated transport using complementary uptake and transcellular models. The findings identify transporter inhibition as a potential determinant of cationic drug secretion and provide a rationale for follow-up interaction studies beyond receptor pharmacology.

• Pentoxifylline Workflows for Inflammation Research

  2026-08-07

  Build reproducible Pentoxifylline assays for macrophage cytokine inhibition, PBMC immunomodulation, and imiquimod-induced psoriasis models. The workflow also shows how optimized niosomes can shift evaluation from simple drug exposure toward controlled skin deposition.

• FLAG tag Peptide (DYKDDDDK): Precision in Protein Detection

  2026-08-07

  Discover how the FLAG tag Peptide (DYKDDDDK) drives reproducible, gentle, and high-specificity purification and detection of recombinant proteins. This guide breaks down advanced experimental workflows, optimization strategies, and troubleshooting insights rooted in structural and translational research.

• miR-18a/ALOXE3 Axis Regulates Ferroptosis and Migration in G

  2026-08-06

  Yang et al. (2021) reveal that miR-18a suppresses ALOXE3, reducing ferroptosis and promoting migration in glioblastoma through altered lipid metabolism and GPCR signaling. These findings highlight the miR-18a/ALOXE3 axis as a promising target for cancer biology research and potential therapeutic intervention.

• Ivermectin in Parasitology Research: Applied Workflows & Ins

  2026-08-06

  Discover how high-purity Ivermectin streamlines anti-parasitic research, from model setup to troubleshooting. This article bridges emerging tumor biology insights with practical workflow enhancements for parasitology drug development.

• Synthetic Viability with ERCC1 Deficiency in Lung Cancer Cel

  2026-08-05

  This article reviews a pivotal study exploring how ERCC1 loss interacts with p53 status to shape DNA crosslink repair and platinum sensitivity in lung cancer. The findings challenge current biomarker paradigms and offer new insights for designing cell cycle-targeted research in oncology.

• Plerixafor (AMD3100): Reliable CXCR4 Inhibition for Lab Succ

  2026-08-05

  This scenario-driven article addresses common laboratory challenges in cell-based assays and translational research, showcasing how Plerixafor (AMD3100) (SKU A2025) delivers robust, reproducible results. Drawing on recent literature and validated protocols, it guides researchers in optimizing workflows for cancer metastasis inhibition, stem cell mobilization, and immunology studies with evidence-backed recommendations.

• BIBR 1532 in Translational Oncology: Telomerase Inhibition R

  2026-08-04

  Explore how BIBR 1532, a potent telomerase inhibitor, enables novel translational oncology applications beyond traditional assay workflows. This in-depth article uncovers mechanistic nuances, synergy with emerging DNA-damaging therapies, and practical assay implications for cancer research.

• Dihydroethidium: Strategic Superoxide Sensing for Translatio

  2026-08-04

  This thought-leadership article delivers a mechanistic and strategic roadmap for translational researchers leveraging Dihydroethidium (DHE, hydroethidine) in oxidative stress and redox biology. By bridging foundational biochemistry with actionable protocol guidance, competitive insights, and clinical context—anchored by recent studies—this piece offers a comprehensive perspective on deploying DHE to drive discoveries in disease models such as acute kidney injury, cardiovascular dysfunction, and beyond. Expanded beyond standard product pages, it contextualizes DHE’s role within the evolving translational research landscape and provides expert recommendations for experimental design and troubleshooting.

449 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page